MedTrace Logo

Randomized Study to Evaluate the Effect of an Investigational Product on Weight Loss and Body Composition

NCT01272739 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-10-06

No results posted yet for this study

Summary

This is a pilot study to determine the safety and efficacy of an investigational product (IHBG-10) on weight loss, and changes in body composition.

Conditions

Interventions

DIETARY_SUPPLEMENT

IHBG-10

500 mg of IHBG-10 taken 15 minutes prior to the three main meals of the day

DIETARY_SUPPLEMENT

Placebo

Placebo taken 15 minutes prior to the three main meals of the day

Sponsors & Collaborators

  • Avera McKennan Hospital & University Health Center

    lead OTHER

Principal Investigators

  • Edward Zawada, MD · Avera McKennan Hospital & University Health Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01272739 on ClinicalTrials.gov